Phreesia reports developments tied to its patient activation platform for healthcare providers, life sciences companies and other organizations. The company’s recurring news includes quarterly results, stakeholder letters, patient intake, outreach, education and appointment-scheduling solutions, and the scale of patient visits enabled through its digital workflows.
Company updates also cover healthcare payment capabilities, including the completed AccessOne acquisition, credit-facility refinancing, and corporate governance or workplace recognition items. Phreesia’s news flow is centered on software, payments and engagement tools used across healthcare delivery and patient interactions.
Phreesia has announced that Sara DiNardo, Vice President of Client Solutions, has been recognized as one of the Top 50 Women Leaders in SaaS of 2022 by The Software Report. This marks the fifth consecutive year a female leader from Phreesia has received such recognition, highlighting the company’s commitment to fostering leadership in the software industry. DiNardo oversees client services and success teams, aiming to enhance the patient experience within the healthcare technology sector.
Phreesia (NYSE: PHR) will release its fiscal Q3 2023 financial results on December 8, 2022, after market close. A press release will be available on ir.phreesia.com, along with a quarterly stakeholder letter. A conference call is scheduled for 5:00 PM ET on the same day to discuss the results. Phreesia provides a SaaS platform for healthcare organizations, improving patient intake and enhancing clinical care.
Phreesia has appointed Alexandra Beneville as Vice President of Life Sciences Content Strategy, effective August 1, 2022. Beneville joins from Phosphorus, where she was Vice President of Marketing. With over 20 years of experience in marketing and brand management within the healthcare sector, she aims to enhance digital patient engagement at Phreesia. Beneville's previous roles include leadership positions at Wunderman and Eli Lilly. Phreesia's Life Sciences division focuses on connecting with patients through targeted health content and insights.
Phreesia announced that Zeeshan Butt, PhD, has been appointed to the National Quality Forum’s Measure Applications Partnership (MAP) Clinician Workgroup for a three-year term. This group influences performance measures for federal public reporting and payment programs. Dr. Butt is a licensed clinical health psychologist specializing in patient-reported outcomes. Phreesia supports over 100 million patient visits annually, offering tools that enhance health outcomes and efficiency in healthcare settings. Its Patient Activation Measure® is recognized for improving clinical results and reducing costs.
Phreesia, Inc. (NYSE: PHR) reported fiscal Q2 2023 results, achieving revenue of $67.9 million, a 33% increase year-over-year, with a total of 2,776 healthcare clients. However, the average revenue per client dipped 7% to $18,248, attributed to faster client growth outpacing revenue gains. Adjusted EBITDA was negative $26 million, worsening from negative $11 million a year ago. The company raised its 2023 revenue outlook to $273-$275 million, indicating 28%-29% growth, and adjusted EBITDA guidance improved but remains negative. Cash equivalents dropped to $240.7 million.
Phreesia, Inc. (NYSE: PHR) will announce its fiscal Q2 2023 financial results after market close on September 7, 2022. A press release detailing the results, accompanied by a quarterly stakeholder letter, will be made available on the company's investor website. Following this, a conference call will commence at 5:00 PM ET to discuss the financial outcomes. Phreesia focuses on enhancing patient intake processes in healthcare through its innovative SaaS platform, promoting patient engagement and operational efficiency.
Summary not available.
Phreesia has released a white paper highlighting how patient expectations of healthcare technology are evolving. Based on a survey of 4,136 patients, it reveals that 84% would book appointments online, while 82% would reschedule similarly. Notably, 64% prefer providers with online check-in options, and 70% are willing to make online payments. The paper indicates a significant demand for digital communication with healthcare providers, as 88% of respondents favor it. Phreesia's insights suggest that enhancing digital capabilities can improve patient satisfaction and retention.
Phreesia, a leader in patient intake solutions, has partnered with Compulink Healthcare Solutions to deliver a bidirectional integration between their systems. This collaboration aims to streamline practice operations, enhance patient collections, and improve overall patient satisfaction. Key features include automated eligibility verification, payment collection, and improved data management. The integration is expected to support practices in maximizing profitability and efficiency, with Phreesia’s systems enhancing patient engagement through personalized experiences.
Phreesia, Inc. (NYSE: PHR) reported fiscal first quarter 2023 results, revealing a 31% revenue growth to $63.4 million compared to $48.3 million last year. The average number of healthcare services clients rose by 33% to 2,526, though average revenue per client fell by 5% to $19,193. Adjusted EBITDA was negative $30.6 million, down from positive $0.1 million in the previous year. The company maintains a fiscal 2023 revenue outlook of $271 million to $275 million, projecting a 27% to 29% growth. Adjusted EBITDA guidance improved, now estimated at negative $126 million to negative $122 million.